Yulia Vugmeyster

3PUBLICATIONS
13CO-AUTHORS
BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Biofabrication
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 02, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer.

Ana Oaknin, Sharad A Ghamande, Yuka Kasamatsu

|Oct 01, 2023
Model-Informed Selection of the Recommended Phase III Dose of the Inhibitor of Apoptosis Protein Inhibitor, Xevinapant, in Combination with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.

Yulia Vugmeyster, Abhigyan Ravula, Elisabeth Rouits

|Sep 06, 2022
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1.

Yulia Vugmeyster, Ana-Marija Grisic, Justin J Wilkins

Pageof 1

Frequent Collaborators

1 joint publications

Paul Matthias Diderichsen

1 joint publications

Kosalaram Goteti

1 joint publications

Karthik Venkatakrishnan

1 joint publications

Ana Oaknin